278 filings
Page 5 of 14
S-3ASR
tce2rjtz
18 Jan 19
Automatic shelf registration
5:01pm
8-K
p8y8xp xxhsj
7 Jan 19
Regulation FD Disclosure
6:13am
10-K
02ax 8houw43kqa
28 Nov 18
Annual report
8:58pm
8-K
l2ep1zwodhav
27 Nov 18
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
4:05pm
8-K
kbxp4tmvgrebhx2tynlf
26 Nov 18
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
4:15pm
8-K
822l2nn 5diygo8sx
5 Oct 18
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs
5:08pm
424B5
m1s4d49eaplwxxsn
3 Oct 18
Prospectus supplement for primary offering
5:30pm
8-K
idm 3jqa2noxq2c38
1 Oct 18
Other Events
4:14pm
424B5
gaxpno5n 34743tz2rvz
1 Oct 18
Prospectus supplement for primary offering
4:12pm
6-K
lmoeqb2e
27 Sep 18
Current report (foreign)
12:00am
8-A12B/A
57kh1 93z847p6t
24 Sep 18
Registration of securities on exchange (amended)
6:09am
6-K
uip8k6h4
21 Sep 18
Current report (foreign)
5:16pm
6-K
yifdk0v7j7n
7 Aug 18
Index to Condensed Consolidated Financial Statements
4:01pm
6-K
5web2p3372dhv017ea
25 Jun 18
Current report (foreign)
4:30pm
6-K
su6nl5sfcev954
24 May 18
Current report (foreign)
4:05pm
6-K
k5e2y
8 May 18
Index to Condensed Consolidated Financial Statements
4:09pm
6-K
jlii cwni9imgd4mpqaa
19 Apr 18
Current report (foreign)
12:00am
6-K
su9ae8pi ap
19 Apr 18
Current report (foreign)
12:00am
6-K
z61c5
6 Apr 18
Current report (foreign)
12:00am
6-K
8wdnln8axct
3 Apr 18
Current report (foreign)
12:00am